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ROLE OF HUMAN LEUCOCYTE ANTIGEN (HLA) AND NON-HLA
GENES IN SUSCEPTIBILITY OR RESISTANCE TO
PULMONARY TUBERCULOSIS
Human beings live in an environment endemic
to various diseases. Under such conditions, some
individuals are susceptible to certain diseases while
most are resistant to those diseases. This raises many
questions. One such question is whether the person
who is susceptible is genetically different from the
person who is resistant to the disease? Similarly, in
a family, one of the parents may be affected with a
particular disease (e.g. diabetes); among the children
born to the parents, if one child (younger one)
develops the disease and the other child (elder one)
does not, the question arises why did the younger
one develop the disease and the elder did not, when
both of them were living together with the affected
parent. This raises the possibility of the disease
being inherited from parents. If genetic factors play 
a major role in disease susceptibility or resistance,
in what way are they associated with the disease
development? Do they control the immune response
to an antigen and/or pathogen? Do they play a role
in the immune mechanism of susceptibility or
resistance to disease? This article gives an account
of disease susceptibility or resistance in pulmonary
tuberculosis in the context of the host genetic factors,
i.e. HLA (Human Leucocyte Antigens) and non-
HLA genes and their gene products.
HLA and disease association - a hypothesis
For considering genetic susceptibility to various
diseases and disease association in the context of
HLA, several hypotheses exist for explaining MHC
(Major Histocompatibility Complex) associated
diseases. The main hypotheses are:-
(1) That HLA A, B, C (Class-I) and DR, DQ and
DP (Class-II) antigens could act directly as
disease susceptibility agents. For this, three
possible mechanisms have been suggested: (a)
There could be antigenic cross reactivity or
mimicry between infectious organisms and a
given HLA antigen. This phenomenon is termed
as “molecular mimicry”. Serological cross-
reaction between HLA 827 antigen and the
bacterial strains Klebsiella and Shigella has been
(2)
(3)
identified1,2. This means that common antigenic
determinants are shared by HLA B27 and the
bacteria; (b) HLA antigens could act as receptors
for microorganism; and (c) HLA antigens could
influence particular immune responses, acting
as immune response (lr) genes. It has been
shown that lr genes regulate the immune
response to any antigen or pathogen).
The MHC genes may be physically close to the
chromosome region that carries a gene
conferring susceptibility or resistance to a
particular disease. This hypothesis may explain
the lack of complete association, and
geographical variation in the association, due
to linkage disequilibrium.
Genetic susceptibility due to non-HLA genes:
Though classical genetic studies in humans and
experimental models have clearly documented
the primary contribution of the MHC genes,
these genes themselves appear to be insufficient
in conferring susceptibility or resistance to
disease.
Susceptibility or resistance to tuberculosis
Pulmonary tuberculosis is a granulomatous lung
disease caused by Mycobacterium tuberculosis.
Susceptibility to tuberculosis has been suggested to
be multifactorial. Though environmental and socio-
economic factors are primarily related, numerous
studies have emphasised the importance of host
resistance and hereditary susceptibility4 ,5.
Susceptibility or resistance to tuberculosis may be
under the control of the genetic make up of an
individual. The host genetic factors such as HLA
(Human Leucocyte Antigen) and non-HLA genes
may be associated with susceptibility or resistance
to tuberculosis.
HLA gene polymorphism
Finding out of HLA and non-HLA genes/gene
products (antigens) which are associated with
susceptibility or resistance to tuberculosis will serve
134 P. SELVARAJ
to provide HLA genetic markers to development of
the disease. Moreover, studying the role of these
markers in the immune mechanism underlying
susceptibility or resistance to tuberculosis will be
useful for understanding the immunopathogenesis
of the disease. Studies of HLA and tuberculosis
susceptibility have been carried out, in populations
as well as in families by several groups in differents
part of the world. The association of various HLAs
with disease susceptibility in different ethnic
population groups has been shown in these studies6-12.
The HLA association shows some geographic
variation. It seems likely that evolutionary selection
pressures have given rise to frequent polymorphisms
in genes involved in resisting infectious pathogens
and contributed to marked allele frequency
differences at the same loci. When geographic
variation in  pathogen polymorphism is
superimposed on host genetic heterogeneity,
considerable variation may occur in detectable allelic
association. Gene-environmental interactions are
likely to introduce another layer of complexity13. The
genes involved in defense against infectious
pathogens evolve more rapidly than others.14 and
excessive polymorphism in the human genome may
result from selection pressures exerted by infectious
diseases. Similarly, the causative organism
M. tuberculosis also has genetic variation. During
evolution, all these polymorphic forms might have
evolved due to the host-parasite interaction.
Studies in non-Asian countries
A large number of HLA association studies have
been carried out in non-Asian countries6-11. One of
the first reports of an association between HLA and
tuberculosis showed an increased frequency of HLA
B8 in Canada6. Other studies showed an increased
frequency of HLA B5, B15 and DR5 in the North
American blacks7,8, HLA A2 and B5 in the Egyptian
population and B27 in the Greek population11. A
negative association has been reported for DR6 in
American blacks9. Since more interesting findings
have been reported from the Asian region, the
discussion is being restricted to the Asian
populations.
Studies in Asian populations
Several studies of HLA association with
pulmonary tuberculosis have been carried out in
Chinese12,15, Korean16, Indonesian17, Indian18-24 and
Russian patients 25. A significantly increased
frequency of HLA-DR2 was seen in the major
studies20,21,23,24,17,25 which have revealed HLA DR2
association with higher susceptibility to tuberculosis.
Of the numerous Indian studies on HLA asso-
ciation with pulmonary tuberculosis18-24, the earlier
ones focussed on association of HLA Class-I anti-
gens18,19 in tuberculosis patients and later, in family
studies in north India21,23 and south India20,24. An
increased frequency of HLA DR2 in pulmonary
tuberculosis patients compared with the control sub-
jects was found. Molecular study has revealed that
the allele DRB1 * 1501 of HLA-DR2 was higher
compared with DRB1 *1502 in north Indian pa-
tients23. While both DRB1 * 1501 and * 1502 were
increased in south Indian patients27, no deviation was
seen between * 1501 and *1502 alleles. Associa-
tion of HLA DP B102 and DQ1 with susceptibility
to pulmonary tuberculosis has also been shown in
patients in south India27. On the other hand, a de-
creased frequency of HLA-DR6 in pulmonary tu-
berculosis patients suggests that DR6 may be asso-
ciated with resistance to tuberculosis21,24.
Previous investigations showed a varied picture
of the association in different populations mainly
because of geographical distribution of antigens and
the ethnic background of the populations. How-
ever, studies carried out in India, Indonesia and
Russia have shown a definite association of HLA
DR2 and DQ1 with pulmonary tuberculosis. It is
well established that DR2 is in linkage
disequilibrium with DQ1.
In a recent study27, HLA DRB1 * 1501, DRB1
*08 HLA DQB1 *0601 (a subtype of HLA-DQ1)
and DPB1 *02 were found to be positively associ-
ated with susceptibility to pulmonary tuberculosis
while a negative association (preventive fractions
associated with resistance) has also been identified
(DRB1 *11(5), DRB1 *10, DQB1 *0501 and DPB1
*08). Haplotype analysis also supports the DRB1
* 1501 -DQB1 *0601 association with susceptibil-
ity to pulmonary tuberculosis.
HLA DR2 and immunity to tuberculosis
The association of HLA DR2 with severity of
pulmonary tuberculosis has also been emphasised
in Indian population. In south Indian patients, DR2
has been shown to be more strongly associated with
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far-advanced, smear positive tuberculosis than with
minimal and moderately advanced disease20.
In Russian patients, DR2 was associated with
chronic fibrocavitary cases who failed to react to
PPD25. Our study has revealed that HLA DR2 is
associated with both low and high tuberculin test
response28, Further, among north Indian patients a
high frequency of DR2 was seen in treatment failures
compared with healthy controls and treatment
responders23. Though severity of the disease is
associated with HLA DR2, follow up of patients
treated with short course chemotherapy did not
reveal any difference in DR2 frequency between
relapse and quiescent patients29.
Patients bearing DR2 antigen have higher level
of antibodies to M. tuberculosis compared with other
patients. Further, there is evidence favouring a
spectrum wherein cell-mediated and humoral
immunity are at the opposing ends of the spectrum.
Our recent study suggests that in active tuberculosis,
patients having DR2 and a trend towards higher
antibody response to M.tuberculosis antigens
possibly show that higher antibody titre may have
suppressed the cell mediated immune response26. It
has been suggested that patients and controls having
DR2 give a high reaction to PPD20. Further study
has revealed that DRB1 * 1501 (a subtype of DR2)
is responsible for greater tuberculin induration
compared with DRB1 * 150230. Similarly, HLA DR2
is found associated with lymphocyte response to
M. tuberculosis culture filtrate antigen both in active
and cured (quiescent) tuberculosis patients31. A
decreased level of plasma lysozyme, a phagocytic
enzyme (lysosomal enzyme) involved in
microbicidal activity has been found in DR2
positives as compared with non-DR2 active
pulmonary tuberculosis patients32. This suggests that
susceptibility to pulmonary tuberculosis is not only
influenced by HLA DR2 genes/gene products but
by non-HLA gene factors as well.
Recently, association of multi candidate genes
has been suggested for various infectious diseases13.
In north Indian pulmonary tuberculosis patients,
compared with control subjects, the “Transporter”
associated with antigen processing gene 2 (TAP2)
has been found associated with active tuberculosis,
along with HLA DR233 Studies on non-HLA gene.
polymorphism have revealed that functional mutant
homozygotes of mannose binding protein genes are
associated with pulmonary tuberculosis independent
of HLA DR234. Moreover, study of Vitamin D
receptor (VDR) gene polymorphism has revealed a
significant increase of VDR mutant homozygotes
(tt) in female patients compared with female contacts
while a significant increase of wild type
homozygotes (TT) was observed among female
contacts compared with female cases35, suggesting
that HLA DR2 gene/gene products in combination
with other HLA and/or non-HLA genes, play a major
role in susceptibility to pulmonary tuberculosis.
Non-HLA gene polymorphism
Non-HLA gene polymorphism studies in
tuberculosis have revealed definite association
between tuberculosis and the haptoglobin 2-2
phenotype36, except in Indonesia37 and India19.
Recently, human genome analysis has revealed
several candidate non-HLA genes, including
cytokine genes, but due to point mutations most of
these non-HLA genes occur as diallelic polymorphic
forms. Such polymorphic genes have been shown
to be associated with susceptibility to a number of
infectious and non-infectious diseases. Some of the
important non-HLA genes are as follows:
Mannose-binding protein
Mannose-binding protein (MBP), also known
as mannose-binding lectin (MBL) is an acute phase
protein secreted by liver. It binds mannose and N-
acetylglucosamine terminated glycoproteins and
plays an important role in host defence against
pathogens. Upon binding with certain carbohydrate
moieties, such as terminal N-acetyl glucosamine or
mannose, on various pathogens, MBP activates
complement via specific protease and acts directly
as an opsonin using the Clq receptor on
macrophages. Mutations are found at the coding
regions of the MBP genes i.e. at codons 52, 54 and
57 that lead to low or near absent serum MBP levels
in heterozygotes and homozygotes, respectively.
Low serum level of MBP is associated with a common
opsonic defect and is frequent in recurrent infections
of infancy and possibly infections in adult life.
Studies carried out in Gambia have revealed that
MBP is  not  associa ted  wi th  pulmonary
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tuberculosis38. But in an Indian population, an
increased genotype frequency of MBP functional
mutant homozygote (including 52, 54 and 57) was
found in pulmonary tuberculosis (10.9%) compared
with control subjects (1.8%). Analysis of association
of MBP genes and HLA DR2 has revealed that these
genes are associated with susceptibility to pulmonary
tuberculosis, independent of each other)‘.
Vitamin D receptor
Vitamin D regulates calcium metabolism.
Vitamin D3 is an immunoregulatory hormone and
activates monocytes and stimulates cell-mediated
immunity. Further, Vitamin D3 is one of the few
mediators which have been shown to impair the
growth of M. tuberculosis in macrophages39. Vitamin
D effects are exerted through interaction with
Vitamin D receptor (VDR). It has been suggested
that the mutant allele of the VDR gene may be
associated with reduced VDR mRNA expression.
Allelic variants of Vitamin D receptor appear to be
associated with differential susceptibility to several
infectious and non-infectious diseases13. Vitamin D
receptor gene polymorphism studied in Gambian
tuberculosis patients suggested that the tt genotype
(mutant) is less frequent in cases of pulmonary
tuberculosis40 but in Indian leprosy patients the tt
genotype has been shown to be associated with
tuberculoid leprosy whereas the opposite TT
genotype is associated with lepromatous leprosy41.
Our study of VDR gene polymorphism in pulmonary
tuberculosis patients revealed a significant increase
in VDR mutant homozygotes (tt) in female patients
as compared with female contacts (spouses of male
patients). Similarly, a significant increase of wild
type homozygotes (TT) was observed in female
contacts compared with female patients. This
suggests that the mutant genotype variant of VDR
gene (tt) is associated with susceptibility to
pulmonary tuberculosis in female patients and the




Studies in mice of acute susceptibility to
infection with Leishmania donovani and Salmonella
typhimurium led to the mapping of a major gene
denoted as Lsh or lty on mouse chromosome-l.
Subsequently, this was found to affect susceptibility
to some strains of BCG (Bacille Calmette Guerin).
This gene is expressed in macrophages and appears
to influence macrophage activation. The equivalence
for the BCG gene is the NRAMP-1 gene, which
encodes for NRAMP-1 protein localised in the
phagosome membrane. Several polymorphisms in
the human homologue NRAMP-1 have been
defined. Genetic linkage and association of
tuberculosis and leprosy have been reported42.
Recently, Bellamy et al 43 have identified variants in
the NRAMP-1 gene that are associated with a
significantly increased risk of pulmonary
tuberculosis in Gambian population. Our study of
one of the NRAMP-1 CA repeat microsatellite
polymorphism at 199 and 201 region of the human
NRAMP-1 gene revealed no such association in
Indian patients (Selvaraj et al., unpublished data)
but other gene polymorphisms of the NRAMP-1
gene are under study.
Cytokine genes and receptors
An analysis of the course of infection in gene-
knock-out mice has provided examples of the
potential relevance ofpolymorphism in cytokine and
cytokine receptor genes to infectious disease
susceptibility in humans.
1) Tumor necrosis factor -a (TNF -a)
Increased production of inflammatory cytokines,
such as tumour necrosis factor-µ (TNF-µ) has been
found in tuberculosis and various other infectious
diseases. The TNF -a is mainly produced by
monocytes and macrophages and variant genes of
TNF -a are associated with increased production of
TNF -a. Association studies have been carried out
on polymorphisms in and near the tumor necrosis
factor (TNF) gene located in class III region of
MHC. Studies of gene polymorphism, at -308
promoter region in Cambodian patients have
revealed no association with TNF -a in tuberculosis
patients44. Our study of TNF-µ and -238 and -308
gene polymorphisms in Indian pulmonary
tuberculosis patients also revealed no association
either with susceptibility or resistance35. However,
studies in Indian leprosy patients have revealed that
the -308 variant is associated with lepromatous
leprosy45.
2) IL-1 receptor antagonist (IL-I RA)
Interleukin-1 receptor antagonist (IL-1 RA) is
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another cytokine which competes for the IL-1
binding site. The production of IL-1 µ and IL-1 ß
is controlled by IL-1 RA. The association of IL-1
RA gene polymorphism has been studied in various
diseases46. Macrophages from carriers of IL-1 RA
allele 2 have been shown to produce more IL-1 RA
and less IL-1 µ than other genotypes47. Our study
of IL-1 RA gene polymorphism in Indian
pulmonary tuberculosis patients revealed no
association with any of the genotypes35 but spinal
tuberculosis patients showed an increased
frequency of genotype 22 compared with the
control subjects (Selvaraj et al., unpublished data).
Non-HLA gene polymorphisms such as
Interferon g receptor/gene polymorphism have shown
recessive susceptibility to atypical mycobacterial
species such as M. fortuitum, M. cheloni and M. avium.
A different mutation was identified in a child with
fatal disseminated BCG infection.
Over the last few years, interest has increased
in both MHC and non-MHC genes that are
important to the immunogenetics of human
infectious diseases. Susceptibility is mainly
determined by a large or very large number of
polymorphic host genes, each contributing a
relatively small effect. Polygenic determination/
candidate gene studies in infectious disease have
been more rewarding than other multifactorial
diseases. With better knowledge of the mechanism
of immunity, variants are being found that are likely
to affect resistance to many infectious pathogens13.
Finding out new MHC and non-MHC genes which
are associated with susceptibility or resistance to
disease will serve as genetic markers for
predetermining development of disease. Moreover,
the role of these multi-candidate genes on the
immune mechanism of disease susceptibility or
resistance will throw light on the mechanism of
susceptibility or resistance to tuberculosis.
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